Posts

Gujarat Inject (Kerala) Ltd. Announces Q1 FY27 Standalone Financial Results; Appoints Mr. Murli Shivshankaran Nair as Managing Director and Advances Strategic Name Change to REGENOVA RENEWTECH LIMITED

-
Q1 FY27 Net Profit reaches Rs. 1.25 Crore, marking a massive year-on-year increase compared to Q1 FY26; Strategic transition into renewable energy and solar solutions moves forward rapidly. Vadodara, Gujarat – July 15, 2026: The Board of Directors of Gujarat Inject (Kerala) Limited (BSE: 524238) today approved the standalone un-audited financial results for the first quarter ended June 30, 2026. The Company has delivered a strong performance, highlighting its robust transition into the high-growth solar and clean energy sector. FINANCIAL PERFORMANCE HIGHLIGHTS Q1 FY27 Revenue from Operations stood at Rs. 12.45 Crore (Rs. 1,245.45 Lakhs), representing a spectacular YoY growth of 414.4% compared to Rs. 2.42 Crore (Rs. 242.12 Lakhs) in Q1 FY26. Q1 FY27 Standalone Net Profit (PAT) rose to Rs. 1.25 Crore (Rs. 125.16 Lakhs), a massive expansion from Rs. 0.07 Crore (Rs. 7.35 Lakhs) in the corresponding quarter of the previous fiscal year. Comparison with Q4 FY26: While the sequential revenue ...
Post a Comment
Read more

गुजरात इंजेक्ट (केरल) लिमिटेड ने Q1 FY27 के स्टैंडअलोन वित्तीय परिणाम घोषित किए; श्री मुरली शिवशंकरन नायर को प्रबंध निदेशक नियुक्त किया तथा REGENOVA RENEWTECH LIMITED के रूप में रणनीतिक ब्रांड परिवर्तन को आगे बढ़ाया

-
Q1 FY27 में कंपनी का शुद्ध लाभ ₹1.25 करोड़ पर पहुँचा, जो Q1 FY26 की तुलना में उल्लेखनीय वार्षिक वृद्धि को दर्शाता है। कंपनी का नवीकरणीय ऊर्जा एवं सौर समाधान क्षेत्र की ओर रणनीतिक परिवर्तन तेज़ी से आगे बढ़ रहा है। वडोदरा, गुजरात | 15 जुलाई, 2026: गुजरात इंजेक्ट (केरल) लिमिटेड (BSE: 524238) के निदेशक मंडल ने आज 30 जून, 2026 को समाप्त पहली तिमाही (Q1 FY27) के स्टैंडअलोन अनऑडिटेड वित्तीय परिणामों को मंजूरी प्रदान की। कंपनी ने उच्च विकास वाले सौर एवं स्वच्छ ऊर्जा क्षेत्र में अपने सफल रणनीतिक परिवर्तन को दर्शाते हुए मजबूत वित्तीय प्रदर्शन किया है। वित्तीय प्रदर्शन की प्रमुख विशेषताएँ Q1 FY27 में परिचालन से प्राप्त राजस्व ₹12.45 करोड़ (₹1,245.45 लाख) रहा, जो Q1 FY26 के ₹2.42 करोड़ (₹242.12 लाख) की तुलना में 414.4% की वार्षिक वृद्धि दर्शाता है। स्टैंडअलोन शुद्ध लाभ (PAT) बढ़कर ₹1.25 करोड़ (₹125.16 लाख) हो गया, जबकि पिछले वित्तीय वर्ष की समान तिमाही में यह ₹7.35 लाख था। Q4 FY26 की तुलना में: यद्यपि राजस्व Q4 FY26 के असाधारण उच्च ऑर्डर निष्पादन तिमाही (₹30.70 करोड़) की तुलना में घटकर ₹12.45 करोड...
Post a Comment
Read more

ગુજરાત ઇન્જેક્ટ (કેરળ) લિમિટેડે Q1 FY27 ના સ્ટેન્ડઅલોન નાણાકીય પરિણામોની જાહેરાત કરી; શ્રી મુરલી શિવશંકરણ નાયરની મેનેજિંગ ડિરેક્ટર તરીકે નિમણૂક કરી અને REGENOVA RENEWTECH LIMITED તરીકે નામ બદલવાની વ્યૂહાત્મક પ્રક્રિયાને આગળ વધારી

-
 Q1 FY27 દરમિયાન કંપનીનો ચોખ્ખો નફો રૂ. 1.25 કરોડ પર પહોંચ્યો, જે Q1 FY26ની સરખામણીએ નોંધપાત્ર વાર્ષિક વૃદ્ધિ દર્શાવે છે. કંપનીનો રિન્યૂએબલ એનર્જી અને સોલાર સોલ્યુશન્સ ક્ષેત્રે વ્યૂહાત્મક પરિવર્તન ઝડપથી આગળ વધી રહ્યું છે. વડોદરા, ગુજરાત – 15 જુલાઈ, 2026: ગુજરાત ઇન્જેક્ટ (કેરળ) લિમિટેડ (BSE: 524238) ના બોર્ડ ઓફ ડિરેક્ટર્સે આજે 30 જૂન, 2026ના રોજ પૂર્ણ થયેલા પ્રથમ ત્રિમાસિક (Q1 FY27) માટેના સ્ટેન્ડઅલોન બિન-ઓડિટેડ નાણાકીય પરિણામોને મંજૂરી આપી છે. કંપનીએ ઉચ્ચ વૃદ્ધિ ધરાવતા સોલાર અને સ્વચ્છ ઊર્જા ક્ષેત્રમાં તેના સફળ વ્યૂહાત્મક પરિવર્તનને પ્રતિબિંબિત કરતી મજબૂત કામગીરી નોંધાવી છે. નાણાકીય કામગીરીની મુખ્ય વિશેષતાઓ Q1 FY27 દરમિયાન ઓપરેશન્સમાંથી આવક રૂ. 12.45 કરોડ (રૂ. 1,245.45 લાખ) રહી, જે Q1 FY26 દરમિયાન રૂ. 2.42 કરોડ (રૂ. 242.12 લાખ)ની સરખામણીએ 414.4% નો વાર્ષિક વધારો દર્શાવે છે. Q1 FY27 નો સ્ટેન્ડઅલોન ચોખ્ખો નફો (PAT) રૂ. 1.25 કરોડ (રૂ. 125.16 લાખ) રહ્યો, જ્યારે ગયા નાણાકીય વર્ષના સમાન ત્રિમાસિકમાં તે માત્ર રૂ. 0.07 કરોડ (રૂ. 7.35 લાખ) હતો. Q4 FY26ની સરખામણીએ: જોકે આવક Q4 FY26ના વિશિષ્ટ...
Post a Comment
Read more

HDFC LIFE PERFORMANCE FOR QUARTER ENDED JUNE 30, 2026

-
BSE Code :540777 NSE Code: HDFCLIFE HDFC Life Q1 FY27: Value of new business (VNB) growth in line with APE growth; 25.0% New Business Margin, healthy growth in protection and annuity Mumbai, July 15, 2026: The Board of Directors of HDFC Life approved and adopted the reviewed standalone and consolidated financial results for the quarter ended June 30, 2026. India remained among the fastest-growing major economies in FY26, supported by resilient domestic demand and continued structural reforms. Growth for FY27 is expected to moderate, largely on account of the ongoing West Asia conflict and its bearing on energy prices. We remain watchful for anymaterialshiftsaswegothroughtheyear.Forthelifeinsuranceindustry,thisbackdropcontinues to reinforce the long-term, protection-led nature of the business, even as the sector adapts to a meaningful pace of regulatory change. India's life insurance opportunity remainssignificantlyunderpenetrated relative to itseconomic size, withaprotectiongapth...
Post a Comment
Read more

Kusumgar Limited Makes Strong Market Debut, Shares List at 37% Premium Over IPO Price

-
Stock reached a high of Rs 625.9 on NSE and Rs 631.4 on BSE   Mumbai, July 15, 2026: Shares of Mumbai-based Kusumgar Limited, a manufacturer of woven, coated and laminated synthetic fabrics, referred to as engineered fabrics, listed at Rs 574 on the exchange, a rise of 37% from IPO price. The scrip reached a high of Rs 625.9 on the NSE, and Rs 631.4 on the BSE. The scrip closed at Rs 604.5 on BSE, and Rs 611 on NSE. As per NSE, the total quantity traded stood at 238.09 lakh shares, on BSE the total Quantity stood at 35.9 lakh shares. Total Turnover (BSE+NSE) on Day 1 stood at Rs 1641 crore. The Market Capitalisation of the Company at today’s closing price stood at Rs 6,346.2 crore as per BSE and Rs 6,415 crore as per NSE. The company had offered a nearly Rs 650 crore issue for subscription. This offer was subscribed nearly 128.85 times, and the Retail Portion and Non-Institutional Portion were subscribed 26.47 times and 165.46 times respectively.  The Qualified Institutional ...
Post a Comment
Read more

Bank of India Officers' Association Organises Health Check-up Camp at BOI Head Office

-
Image
            Commemorating the upcoming 57th Bank Nationalisation Day and reaffirming its commitment to employee welfare, the Bank of India Officers' Association (BOIOA) organised a comprehensive Health Check-up Camp today at the Bank's Head Office in Mumbai in association with Kokilaben Dhirubhai Ambani Hospital. The camp featured various specialised medical tests including BMD, audiometry, ENT, uroflowmetry, orthopaedic, pain management and dietician consultations. Around 630 employees of the Head Office enthusiastically availed themselves of the facilities. The camp was inaugurated by Bank of India MD & CEO Shri Rajneesh Karnatak in the august presence of Executive Directors Shri Rajagopal, Shri Subrat Kumar, Shri Rajeev Mishra & Shri Pramod Dwibedi. The occasion was further graced by CVO Shri Lalit Taneja and distinguished presence of several CGMs, GMs and other senior executives of the Bank. The programme was conceived and executed under the lea...
Post a Comment
Read more

SBI Funds Management Limited’s IPO Subscribed 68 Percent on Day 1 of IPO

-
Non-institutional investors (NII) portion subscribed 1.39 times on Day 1 Issue closes on Thursday, July 16, 2026, for bidding   Mumbai, July 14, 2026: The Initial Public Offering of SBI Funds Management Limited was subscribed 0.68 times on the first day of bidding, demonstrating strong demand from retail, employees and non-institutional investors (NII) for this IPO. The issue received bids of 8,50,65,656 equity shares against the offered 12,45,63,536 equity shares, according to data available on the stock exchanges. The Non-Institutional Portion and Retail Portion were subscribed 1.39 times and 0.62 times, respectively. The Qualified Institutional Investors (QIB) portion was subscribed 0.08 times, while the Employee Reserved Quota was subscribed 1.02 times. The issue kicked off for subscription on Tuesday, July 14, 2026, and will close for subscription on Thursday, July 16, 2026. A day before the opening of the issue, SBI Funds Management Limited had raised nearly ₹2,663 crore fro...
2 comments
Read more